|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1989-3-27
|
|
pubmed:abstractText |
An attenuated vaccinia virus mutant with specific genetic lesions has been used to develop a vehicle for safer live recombinant virus vaccines. The mutant virus 48-7 has an 8-MDa deletion starting 2.2 MDa from the left end of the viral genome and point mutations in the gene encoding the 14-kDa fusion protein that determines the plaque-size phenotype of the virus. Using the highly sensitive reporter gene luciferase, we have shown that this mutant can generate recombinant viruses that infect cultured cells and animals with normal vaccinia virus tropism. Insertion of the envelope and gag genes of human immunodeficiency virus type 1 into the attenuated vaccinia mutant resulted in their efficient expression and precursor processing in infected cultured cells. Infection of mice with human immunodeficiency virus-vaccinia recombinant viruses elicited human immunodeficiency virus-specific antibodies. Using mice pretreated with cyclophosphamide as a model for immunosuppression, the reduced virulence of the mutant recombinant virus was clearly evident. These findings demonstrate that the highly attenuated vaccinia virus mutant 48-7 can be used to generate effective and safer vaccines.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-17758108,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-2410792,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-2439103,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-2441522,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-2447506,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-2578227,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-2981635,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-2982104,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-2987924,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-3008001,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-3008002,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-3118219,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-3316708,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-3422754,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-3474420,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-3475856,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-3496541,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-3498904,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-3821799,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-3939316,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-3945343,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-4058585,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-4186802,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-6289324,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2784004-6296831
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0027-8424
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
86
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1287-91
|
|
pubmed:dateRevised |
2010-9-10
|
|
pubmed:meshHeading |
pubmed-meshheading:2784004-Cloning, Molecular,
pubmed-meshheading:2784004-Gene Products, gag,
pubmed-meshheading:2784004-Genes,
pubmed-meshheading:2784004-Genes, Viral,
pubmed-meshheading:2784004-HIV-1,
pubmed-meshheading:2784004-Kinetics,
pubmed-meshheading:2784004-Luciferases,
pubmed-meshheading:2784004-Mutation,
pubmed-meshheading:2784004-Recombinant Proteins,
pubmed-meshheading:2784004-Recombination, Genetic,
pubmed-meshheading:2784004-Retroviridae Proteins,
pubmed-meshheading:2784004-Vaccinia virus,
pubmed-meshheading:2784004-Viral Envelope Proteins,
pubmed-meshheading:2784004-Virulence
|
|
pubmed:year |
1989
|
|
pubmed:articleTitle |
Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses.
|
|
pubmed:affiliation |
Department of Biochemistry, State University of New York Health Science Center, Brooklyn 11203.
|
|
pubmed:publicationType |
Journal Article
|
